Form 4 Celcuity LLC For: 12 June
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Celcuity LLC (CELC)
The Celcuity share price today is 88.73, view NASDAQ CELC stock exchange data. Track the latest Celcuity share price with real-time updates on CELC stock performance including market cap, day range, 52-week range and dividend yield. Access CELC charts, earnings dates and analyst estimates to support your investment decisions.
88.73
+1.41(+1.61%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
86.35
88.85
52 wk Range
11.28
151.02
CELC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
86.3588.85
52 wk Range
11.28151.02
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CELC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
161.09
Upside
+81.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 4 Celcuity LLC For: 12 June
- Investing.com
- Why is Celcuity stock sliding today?
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
12 Buy
0 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 161.09
(+81.55% Upside)
Celcuity LLC Earnings Call Summary for Q1/2026
- Celcuity reported Q1 2026 EPS of -$0.97, beating analyst estimates of -$1.04 by 6.73%; stock rose 0.82% in aftermarket trading to $125.49.
- Net loss widened to $46.8M from $34.7M year-over-year; company maintains strong cash position of $387.1M to fund operations through 2027.
- Lead drug candidate gedatolisib showed promising clinical trial results for HR-positive, HER2-negative advanced breast cancer treatment.
- Management expressed confidence in meeting operational milestones despite high cash burn rate and increased administrative expenses.
- Stock delivered 1,141% return over past year, though InvestingPro analysis suggests current valuation appears overvalued at 59.83x Price/Book.
Last Updated: 15-05-2026, 03:10 am
Read Full TranscriptEarnings
Latest Release
14-05-2026
EPS / Forecast
-0.97 / -1.04
Revenue / Forecast
-- / 4.7M
Compare CELC to Peers and Sector
Metrics to compare | CELC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCELCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.0x | −1.2x | −0.5x | |
PEG Ratio | 0.80 | −0.02 | 0.00 | |
Price/Book | 79.3x | 2.5x | 2.6x | |
Price / LTM Sales | - | 5.7x | 3.0x | |
Upside (Analyst Target) | 89.0% | 187.5% | 58.6% | |
Fair Value Upside | Unlock | 12.0% | 10.2% | Unlock |
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Celcuity (CELC) Share Price Today?
The Celcuity share price today is 88.73.
What is the current Celcuity (CELC) share price and day range?
As of 17-06-2026, the Celcuity share price is 88.73, with a previous close of 87.32. The share price has ranged from 86.35 to 88.85 today, while the 52-week range spans from 11.28 to 151.02.
What Is the Celcuity Market Cap?
As of today, Celcuity market cap is 4.29B.
What Is the Celcuity (CELC) Share Price Target?
The average 12-month share price target for Celcuity is 161.09, with a high estimate of 175 and a low estimate of 145. 12 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +81.55% Upside potential.
What Is Celcuity's Earnings Per Share (TTM)?
The Celcuity EPS (TTM) is -3.89.
When Is the Next Celcuity Earnings Date?
Celcuity will release its next earnings report on 06-08-2026.
From a Technical Analysis Perspective, Is CELC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Celcuity Trade On?
Celcuity is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Celcuity?
The stock symbol for Celcuity is "CELC."
How Many Times Has Celcuity Stock Split?
Celcuity has split 0 times.
How Many Employees Does Celcuity Have?
Celcuity has 155 employees.
What Is the CELC Premarket Price?
CELC's last pre-market stock price is 87.37. The pre-market share volume is 930.00, and the stock has changed by 0.05, or 0.06%.
What Is the CELC After Hours Price?
CELC's last after hours stock price is 87.91, the stock has changed by 0.59, or 0.68%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.